Indoco Remedies slumps to near 3-year low on FDA concerns
Monday, April 3, 2017, 12:48 PM
The US Food and Drug Administration (FDA) raised six observations in the form 483 for the company's Goa manufacturing facility inspected last year. It accepted the company's response on four observations, but raised concerns over the remaining two. The observations related to a specific product for which the company is a contract manufacturer.